Greenlight Analytical IPO

www.greenlightanalytical.com/Consumer & Lifestyle / Cannabis & Tobacco

Greenlight Analytical is a biotechnology research company that analyzes agriculture to improve the quality of crops. Using its HarvestIQ technology, the company can adjust to the growing environment and reach higher revenue for crop producers. Other features include residual pesticide measuring, chemical profiles throughout the growth cycle, and terpene profiling. Greenlight Analytical was founded by James Wylde and Simon Benwell in 2018 and is headquartered in Nova Scotia, Canada.

Buy or sell Greenlight Analytical stock Learn more about Greenlight Analytical stock

Learn more about Greenlight Analytical

Is Greenlight Analytical a publicly traded company?

Greenlight Analytical is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Will Greenlight Analytical go IPO?

Greenlight Analytical has not yet filed for an IPO. However, it's important to note that IPOs are not the sole avenue for a private company to transition to public trading. Private companies can also go public through alternative methods such as but limited to Special Purpose Acquisition Companies (SPACs), direct listings, or through mergers and acquisitions. Find out which companies are eyeing an IPO on our Tech IPO Calendar 2024.

What is Greenlight Analytical's IPO price?

The IPO price for Greenlight Analytical will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.

Can you invest in Greenlight Analytical pre-IPO?

Greenlight Analytical is privately held company and is not publicly traded, therefor investing in Greenlight Analytical pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

What is the value of my Greenlight Analytical shares?

To determine the value of your Greenlight Analytical shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Greenlight Analytical shares. You can also learn more about how to sell your private shares before getting started.

Can you sell Greenlight Analytical before it goes public?

Yes, you can seek to sell shares in Greenlight Analytical while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

When was Greenlight Analytical founded?

Greenlight Analytical was founded in 2018.

Who are Greenlight Analytical's major investors?

Mitacs

Invest Nova Scotia

Emera ideaHUB

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.